As COVID-19 has led to a range of challenges for business, they have been forced to rethink and address their supply chain. Find KPMG insights on the related tax considerations and tax planning below.
July 6, 2020
Economies around the world are in the midst of a severe downturn brought about by measures taken to contain Covid-19. As a result, multinational enterprises' transfer prices may need to be adjusted. In this article, the authors discuss some potential approaches for adjusting profit benchmarks for controlled entities in the CPM/TNMM context, consistent with the arm's-length standard.
July 1, 2020
In this article, the authors focus on some of the significant international tax and transfer pricing issues, including supply chain, consumer demand, and cash flow, arising from companies' activities disrupted by TCJA and COVID-19.
June 29, 2020
In this article, the authors examine key trends affecting the life sciences industry in the COVID-19 pandemic and the associated transfer pricing considerations.
May 25, 2020
This article explains how recent changes to the U.S. advance pricing agreement (APA) confirm the potential to amend existing APAs and highlight the value of the APA process to address extraordinary economic disruption through tailored long-term solutions.
May 18, 2020
COVID-19 is causing multinational corporations to reassess transfer pricing (TP) policies and consider making TP adjustments or additional payments. Customs risks and opportunities exist, and in the current high-tariff environment, the duty costs can be significant. This article highlights related compliance and planning issues, which may require advance customs, accounting, and TP coordination and planning.
May 11, 2020
This article discusses significant challenges posed by COVID-19 disruption and some of the key issues for life sciences companies from tax, trade and valuation perspectives, covering supply chain, financing and cash flow, and research and development. Possible post-COVID-19 trends, opportunities, and issues for the industry are also discussed.
March 26, 2020
Many multinational companies deploy limited risk structures, such as contract manufacturing or limited risk distribution, in their global operations, including China.This article sets out what taxpayers should consider in analyzing the steps to be taken to manage transfer pricing risk in light of declines in profits of limited risk companies resulting from the demand supply shocks caused by the COVID-19 outbreak.